EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Linear DNA vaccine: a new approach to overcome the limitations of classical DNA vaccines, using avian influenza A/H5 prevention as an example

M. B. Borgoyakova, N. B. Rudometova, V. А. Filatova, D. А. Filippova, E. V. Starostina, E. V. Yakovleva, A. S. Gudymo, O. N. Perfileva, K. I. Ivanova, K. P. Makarova, V. A. Yakovlev, D. N. Kisakov und 6 weitere

Journal of microbiology, epidemiology and immunobiology · 15.11.2026 · 103 (5) · 669-679

DOI: 10.36233/0372-9311-902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of microbiology, epidemiology and immunobiology, online erschienen am 15.11.2026. Verfasst von M. B. Borgoyakova und 17 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Highly pathogenic avian influenza viruses of the A/H5 subtype pose a serious threat to public health due to their high mortality rate (over 50 % among reported cases) and the potential risk of acquiring the ability to transmit between humans. Developing effective vaccine platforms, including DNA vaccines, is a priority task. The Doggybone™ linear DNA vaccine technology overcomes the limitations of classical plasmid DNA vaccines (the presence of bacterial elements and antibiotic resistance genes) while retaining their advantages, such as high production speed that does not require using cell cultures or chicken embryos, temperature stability, and cost‑effectiveness.

Aim

Developing a linear DNA vaccine encoding the haemagglutinin of the highly pathogenic avian influenza virus of the A/H5 subtype and evaluation its immunogenicity and protective efficacy in BALB/c mice. Materials and methods. The linear DNA vaccine db‑H5 was produced using the Doggybone™ technology with φ29 DNA polymerase and TelN protelomerase. The functionality of db‑H5 in vitro was assessed by Western blot analysis. For the in vivo study, BALB/c mice were immunized with 1 µg of the DNA vaccine via jet injection. Immunogenicity was evaluated using ELISA, virus neutralization, and IFN‑γ ELISpot assays. Protective efficacy was tested by challenging the animals with the A/Astrakhan/3212/2020 (H5N8) virus.

Results

The resulting linear DNA ensured the expression of the target gene in transfected HEK293 cells. Mice immunized with the db‑H5 DNA vaccine showed high titres of haemagglutinin‑specific antibodies (1:72 900), neutralizing antibodies (median titre 1:40), and increased numbers of IFN‑γ‑producing splenocytes (48 SFUs/10⁶). The survival rate of immunized mice after lethal challenge with 20MLD50 was 70 %, whereas all animals in the control group died.

Conclusions

For the first time in Russian practice, we have demonstrated the feasibility of developing a linear DNA vaccine against diseases caused by highly pathogenic avian influenza A/H5 viruses using the Doggybone™ technology. Two‑dose immunization of mice with an low dose (1 µg) provides protection against lethal infection, which justifies further development of this platform.

Zitieren

APA

Borgoyakova, M. B., Rudometova, N. B., Filatova, V. А., Filippova, D. А., Starostina, E. V., Yakovleva, E. V., Gudymo, A. S., Perfileva, O. N., Ivanova, K. I., Makarova, K. P., Yakovlev, V. A., Kisakov, D. N., Kisakova, L. A., Vakhitov, D. I., Karpenko, L. I., Ilyichev, A. A., Marchenko, V. Y., & Rudometov, A. P. (2026). Linear DNA vaccine: a new approach to overcome the limitations of classical DNA vaccines, using avian influenza A/H5 prevention as an example. Journal of microbiology, epidemiology and immunobiology, 103(5), 669-679. https://doi.org/10.36233/0372-9311-902

Vancouver

Borgoyakova MB, Rudometova NB, Filatova VА, Filippova DА, Starostina EV, Yakovleva EV, et al. Linear DNA vaccine: a new approach to overcome the limitations of classical DNA vaccines, using avian influenza A/H5 prevention as an example. Journal of microbiology, epidemiology and immunobiology. 2026;103(5):669-679. doi:10.36233/0372-9311-902

BibTeX
@article{Borgoyakova2026,
  author = {Borgoyakova, M. B. and Rudometova, N. B. and Filatova, V. А. and Filippova, D. А. and Starostina, E. V. and Yakovleva, E. V. and Gudymo, A. S. and Perfileva, O. N. and Ivanova, K. I. and Makarova, K. P. and Yakovlev, V. A. and Kisakov, D. N. and Kisakova, L. A. and Vakhitov, D. I. and Karpenko, L. I. and Ilyichev, A. A. and Marchenko, V. Yu. and Rudometov, A. P.},
  title = {Linear DNA vaccine: a new approach to overcome the limitations of classical DNA vaccines, using avian influenza A/H5 prevention as an example},
  journal = {Journal of microbiology, epidemiology and immunobiology},
  year = {2026},
  volume = {103},
  number = {5},
  pages = {669--679},
  doi = {10.36233/0372-9311-902}
}
Kostenlos starten →